Toutes les études
RecrutementObservationnel

Description and study of the steroid Metabolome in mucinous ovarian cancer

This research aims to discover better ways to diagnose and track a very rare type of cancer called mucinous ovarian cancer. Doctors need new tools to understand how patients are responding to treatment. The study is investigating if urine tests can be useful by looking for certain substances. There are three main groups of participants: women with ovarian cysts, women who have had mucinous ovarian cancer and finished treatment, and women with certain bowel cancers. Researchers believe that the information gathered could lead to new tests and treatments for ovarian cancer, potentially helping patients in the future. The study involves collecting urine samples at home and at the hospital.

En un coup d'œil

Statut
Recrutement
Sponsor
Université de Birmingham
Objectif d'inscription
340
Démarrer
01 Sep 2025
Achèvement estimé
01 Sep 2027

De quoi parle cette étude ?

This research project is all about finding new and better ways to understand and diagnose a very rare type of cancer called mucinous ovarian cancer. Currently, it can be quite tricky for doctors to find out exactly where some of these cancers come from, and to know how well treatments are working for patients.

The main idea behind this study is to see if we can use simple urine tests to help. The researchers are looking for special substances in urine that might act as clues for diagnosing the cancer and checking its progress. By studying these substances, they hope to develop new tests that could be really helpful for people with ovarian cancer. They are also comparing results from ovarian cancer patients with those who have certain types of bowel cancer to learn more.

The study is divided into three main groups. One group includes women who are having surgery for growths on their ovaries. Another group involves women who have already been treated for mucinous ovarian cancer, and the third group focuses on women with certain types of bowel cancer. The goal is to collect different types of information and urine samples from these groups to get a complete picture. The ultimate aim is that this research could lead to new tools that doctors can use to diagnose and monitor ovarian cancer more effectively, which would be fantastic for future patients.

Points clés

  • Aims to find new ways to diagnose and monitor a rare type of ovarian cancer.
  • Investigates if urine tests can identify specific substances linked to the cancer.
  • Involves collecting urine samples at home over a 24-hour period.
  • Could lead to future diagnostic tests or treatments for ovarian cancer.
  • Participation may involve one or several urine collections over two years.
  • Strict measures are in place to protect your personal information.

Qui peut être éligible ?

This study is open to women aged 18 or over. It's important that you understand the study and agree to take part. There are three different parts, and who can join depends on your current health situation.

For the first part, you might be eligible if you are having surgery for a growth on your ovary, or if you have recently been diagnosed with mucinous ovarian cancer and haven't started treatment yet. For the second part, you might be able to join if you have finished your first round of treatment for mucinous ovarian cancer.

Finally, for the third part, you could be eligible if you have a condition called pseudomyxoma peritonei or certain types of appendiceal (bowel) cancers. There are also specific reasons why you might not be able to join, such as if you've recently used hormonal contraception, hormone replacement therapy, or steroid treatments.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Are you a woman aged 18 or older?
  2. Can you understand the study information and give your consent?
  3. Have you been diagnosed with mucinous ovarian cancer, or are you having surgery for an ovarian mass?
  4. Do you have a diagnosis of pseudomyxoma peritonei or certain types of appendiceal cancer?
  5. Have you avoided hormonal contraception, HRT, or steroid treatments in the last three months (this might apply to some parts of the study)?
  6. Have you not started chemotherapy for ovarian cancer yet (if joining the diagnostic part)?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you decide to take part, you'll first receive a detailed information sheet about the study, and everything will be explained clearly. If you're happy to go ahead, you'll sign a consent form. Then, you'll answer some questions about yourself and your health.

The main thing you'll be asked to do is collect all your urine over a 24-hour period, in your own home, at a time that suits you. You'll be given a special bottle for this. This urine sample will then be collected when you next visit the hospital.

If you're in the first or third part of the study, you'll only need to do this urine collection once. If you're in the second part of the study, you'll be asked to collect urine about every three months for two years. The researchers will try to arrange these collections to fit in with your regular hospital appointments, so it should be as convenient as possible.

Risques et avantages potentiels

While taking part in this study, you might not feel any direct benefit yourself. However, the information gathered from your samples is incredibly valuable. It could help researchers develop new tests or treatments for ovarian cancer in the future, which would benefit many others. We take great care to protect your privacy, but as with any research involving personal information, there's always a very small risk to keeping your data confidential. We have strict rules and secure systems in place to keep your information safe. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Emplacements (10)

Certains emplacements de site sont approximatifs. Nous améliorons cela — veuillez vérifier avec l'équipe d'essai avant de vous déplacer.
  • Fondation des Hôpitaux Universitaires de Birmingham NHS
    Ville uniquement
    Birmingham, Angleterre
  • Cardiff ECMC
    Ville uniquement
    Cardiff, Wales
  • Hinchingbrooke Hospital (hinchingbrooke Healthcare Trust)
    Ville uniquement
    Huntingdon, England
  • Nottingham University Hospitals NHS Trust - Queen's Medical Centre Campus
    Ville uniquement
    Nottingham, England
  • The Christie at Home
    Ville uniquement
    Manchester, England
  • University Hospitals Sussex NHS Foundation Trust
    Ville uniquement
    Worthing, England
  • The Guys and Lewisham NHS Trust
    Ville uniquement
    London, England
  • Hammersmith Hospitals NHS Trust
    Ville uniquement
    London, England
  • University Hospitals of North Midlands NHS Trust
    Ville uniquement
    Stoke-on-trent, England
  • Sandwell and West Birmingham Hospitals NHS Trust
    Ville uniquement
    Smethwick, England

Questions fréquentes

What is mucinous ovarian cancer?

It's a very rare type of cancer that starts in the ovaries. This study is trying to find better ways to diagnose and monitor it.

Why do I need to collect urine?

Researchers are looking for specific substances (called 'biomarkers') in your urine that might help diagnose the cancer or show how treatment is working.

Vais-je recevoir mes résultats de test ?

The study aims to gather overall information, not to provide individual test results that would affect your personal medical care.

Combien de temps l'étude durera-t-elle pour moi ?

It depends on which part of the study you join. Some people collect urine once, while others do so every three months for up to two years, usually during their regular appointments.

Qui finance cette recherche ?

The study is funded by The Eve Appeal and the Birmingham Women’s and Children’s Hospital Global Research Fund.

Comment en savoir plus

Rachel Iles

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "Description and study of the steroid Metabolome in mucinous … vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.